Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06163534 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

StatusRecruiting
PhaseNot specified
SponsorTempus AI
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 30 to 32v27
  2. Site contacts updated at 2 of 30 sitesv26
  3. Study sites: 29 to 30v25
  4. Site contacts updated at 3 of 29 sitesv24
  5. Site contacts updated at 6 of 29 sitesv23
Show 21 earlier versionsHide 21 earlier versions
  1. Study sites: 27 to 29v22
  2. Study sites: 23 to 27v21
  3. Study sites: 18 to 23v20
  4. Study sites revised (18)v19 See this version in full on ClinicalTrials.gov ↗
  5. Study sites: 17 to 18v18
  6. Site contacts updated at 17 of 17 sitesv17
  7. Study sites: 16 to 17v16
  8. Study sites: 14 to 16v15
  9. Study sites: 13 to 14v14
  10. Study sites: 12 to 13v13
  11. Study sites: 11 to 12v12
  12. Study sites: 8 to 11v11
  13. Study sites: 4 to 8v10
  14. Study sites: 3 to 4 Start date changed from estimate of Aug 2024 to Aug 1, 2024 · Eligibility criteria shortened, about 3 wordsv9 Show 2 more changesShow less
    • Start date changed from estimate of Aug 2024 to Aug 1, 2024
    • Eligibility criteria shortened, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  15. Start date: May 2024 to Aug 2024 Study sites: 2 to 3v8 Show 1 more changeShow less
    • Study sites: 2 to 3
  16. Study sites: 1 to 2v7
  17. Start date: Apr 29, 2024 to May 2024v6
  18. Trial status: Not Yet Recruiting to Recruiting Start date: Mar 1, 2024 to Apr 29, 2024 · Study sites: 0 to 1v5 Show 2 more changesShow less
    • Start date: Mar 1, 2024 to Apr 29, 2024
    • Study sites: 0 to 1
  19. Start date: Jan 30, 2024 to Mar 1, 2024 Primary and study completion dates: Jan 30, 2028 to Mar 1, 2028v4 Show 1 more changeShow less
    • Primary and study completion dates: Jan 30, 2028 to Mar 1, 2028
  20. Re-verified, no change to tracked fieldsv3
  21. Start date: Dec 30, 2023 to Jan 30, 2024 Primary and study completion dates: Dec 30, 2028 to Jan 30, 2028v2 Show 1 more changeShow less
    • Primary and study completion dates: Dec 30, 2028 to Jan 30, 2028
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is a prospective, longitudinal, non-interventional, multicenter study of participants with HNSCC who will have tissue and blood based molecular biomarker profiling during their standard of care treatment.
Trial Details
NCT Number NCT06163534
Lead Sponsor Tempus AI
Collaborators: AstraZeneca
Conditions Head and Neck Squamous Cell Carcinoma
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov